Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neptune Technologies & Bioressources Inc (NASDAQ:NEPT)

1.07
Delayed Data
As of Sep 27
 +0.0089 / +0.84%
Today’s Change
0.86
Today|||52-Week Range
1.30
-0.10%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$82.7M

Company Description

Neptune Technologies & Bioresources, Inc. engages in the development and commercialization of marine derived omega-3 polyunsaturated fatty acids. It operates through three segments: Neptune, Acasti and NeuroBio. The Neptune segment involves the production and commercialization of nutraceutical products. The Acasti segment involves the development and commercialization of medical food and pharmaceutical products for cardiovascular diseases. The NeuroBio segment involves the development of medical food and pharmaceutical products for neurological diseases. The company was founded by Henri Harland on October 9, 1998 and is headquartered in Laval, Canada.

Contact Information

Neptune Technologies & Bioresources, Inc.
545, Promenade du Centropolis
Laval Quă©bec H7T 0A3
P:(450) 687-2262
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

James S. HamiltonPresident, Chief Executive Officer & Director
Marie Chantal TurcotteChief of Operations & Technical Services
Mario ParadisChief Financial Officer
Michel TimperioHead-Strategic Development
John R. RipplingerDirector-Investor Relations